#$%^&*AU2016231523B220180531.pdf#####ABSTRACT The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies. 3907955 1.docx27/9 FIGURE 7 Peanut Flour Diluent Low Dose Strengths (1) First Blend (10 min) Addition of 45% of IV Diluent (2) Second Blend (10 min) I Addition of I___ Remaining Diluent (3) Third Blend (15 min) Addition of Glidant (4) Final Blend and/or Lubricant (5 min) i >;4 (5) Blended Sampling ) Discharge Blended Powder For Encapsulation 4 E (6) Encapsulate in Size 3 HPMC Capsules